Edition:
International

Health News Headlines

Drug makers lure defensive investors

Setbacks for several large drug makers last week underscored the risks of the pharmaceutical sector, but they failed to spook stock investors who see the industry as a safer bet in rocky economic times.

BioSante CEO keeps eye on elusive prize

In a space littered with failure, tiny BioSante Pharmaceuticals Inc believes it can succeed in finally bringing a treatment for female sexual dysfunction to the U.S. market.

Risks aside, drug makers lure defensive investors

Setbacks for several large drug makers last week underscored the risks of the pharmaceutical sector, but they failed to spook stock investors who see the industry as a safer bet in rocky economic times.

Naples waste linked to death and disease

Piles of trash building up in Naples have filled the air with a putrid stench and spoiled the view for tourists, but the city's waste crisis may also be killing its people. Standing at the barricades erected by local people to stop the authorities reopening an old landfill in the Pianura neighbourhood, Salvatore Mele, whose son died of cancer, believes the illness was caused by pollution from trash.

HMOs will be mainstay in Medicare for years

Health insurers, which took a major role in Medicare under Republican U.S. President George W. Bush, will likely remain a mainstay in the program for years to come, even if a Democrat wins the White House.

U.S. company claims cloned humans, made stem cells

A California company said on Thursday it used cloning technology to make five human embryos, with the eventual hope of making matched stem cells for patients. Stemagen Corp. in La Jolla, California, destroyed the embryos while testing to make sure they were true clones. But the researchers, based at a fertility center, said they believed their ready source of new human eggs would make their venture a success.

Calif. company sees fertile ground in stem cells

A small California company set up by an unnamed investor and a top fertility doctor burst into the stem cell field on Thursday with a report that it is the first lab to clone human embryos and prove it.

Risks aside, drug makers lure defensive investors

Setbacks for several large drug makers last week underscored the risks of the pharmaceutical sector, but they failed to spook stock investors who see the industry as a safer bet in rocky economic times.

Politics Video

Politics News